QUOTE AND NEWS
Motley Fool  Jul 16  Comment 
St. Jude Medical, Abbott Laboratories, Eli Lilly, and Pfizer are the top health care stocks to watch this morning.
Benzinga  Jul 16  Comment 
Eli Lilly and Company (NYSE: LLY) today announced new data showing that beta-amyloid imaging was associated with altered diagnosis and management of patients with Alzheimer's disease. Change in management was observed in both patients who met and...
Financial Times  Jul 16  Comment 
Deal with Immunocore adds to current alliances and will focus on developing new generation of oncology drugs to harness immune system to kill cancer cells
Jutia Group  Jul 16  Comment 
[PR Newswire] - OXFORD, England and INDIANAPOLIS, July 16, 2014 /PRNewswire/ -- Eli Lilly and Company (LLY) and Immunocore Limited today announced they have entered into a co-discovery and co-development collaboration to research and potentially...
Benzinga  Jul 14  Comment 
Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) today announced that it has acquired Sollpura (liprotamase), a novel investigational Pancreatic Enzyme Replacement Therapy ("PERT") from Eli Lilly and Company. Sollpura is a soluble, stable and...
newratings.com  Jul 13  Comment 
INDIANAPOLIS (dpa-AFX) - Eli Lilly and Co. (LLY) Sunday said its non-clinical study in genetically engineered mice examining combination therapy was more effective in removing clumps of amyloid-beta protein in the brain. The drug maker utilised...
Jutia Group  Jul 10  Comment 
[PR Newswire] - INDIANAPOLIS, July 10, 2014 /PRNewswire/ -- Eli Lilly and Company (LLY) has rebooted the Lilly for Better Health™ program, with several innovative enhancements to lillyforbetterhealth.com that help enrich the user experience with...
TheStreet.com  Jul 8  Comment 
NEW YORK (TheStreet) -- Shares of Eli Lilly and Co. are down -0.40% to $62.36 after Sn">anofi SA , whose top-selling Lantus helps diabetics control blood sugar levels, filed a lawsuit accusing Lilly of infringing seven patents related to insulin...
Reuters  Jul 8  Comment 
Sanofi SA, whose top-selling Lantus helps diabetics control blood sugar levels, has filed a lawsuit accusing Eli Lilly and Co of infringing seven patents related to insulin and devices used to deliver it.
Motley Fool  Jul 7  Comment 
The CHMP recommends approval for Lantus biosimilar insulin




 

Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki